Page last updated: 2024-12-09
4-(trifluoromethyl)phenylalanine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4-(trifluoromethyl)phenylalanine: an unnatural amino acid; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 2777605 |
| SCHEMBL ID | 43861 |
| MeSH ID | M0556697 |
Synonyms (37)
| Synonym |
|---|
| l-4-trifluoromethylphenylalanine |
| AKOS000197414 |
| 2-amino-3-[4-(trifluoromethyl)phenyl]propanoic acid |
| FT-0656135 |
| (2r)-2-amino-3-[4-(trifluoromethyl)phenyl]propanoic acid |
| A807706 |
| 2-amino-3-[4-(trifluoromethyl)phenyl]propanoic acid;4-(trifluoromethyl)-dl-phenylalanine |
| (r)-beta-(p-trifluoromethylphenyl)alanine |
| dl-4-trifluoromethylphenylalanine |
| 4-(trifluoromethyl)-dl-phenylalanine |
| 14091-16-8 |
| 2-amino-3-(4-trifluoromethyl-phenyl)-propionic acid |
| 2-amino-3-(4-(trifluoromethyl)phenyl)propanoic acid |
| 4-trifluoromethyl-dl-phenylalanine |
| A13011 |
| FT-0616929 |
| FT-0649689 |
| AB02826 |
| AKOS022172749 |
| SCHEMBL43861 |
| FS-1156 |
| dl-phenylalanine, 4-(trifluoromethyl)- |
| 4-(trifluoromethyl)phenylalanine |
| mfcd00070813 |
| h-d-phe(4-cf3)-oh.hcl |
| h-phe(4-cf3)-oh |
| 3-(4-trifluromethyl phenyl)alanine |
| SY044829 |
| boc-s-acetamidomethyl-l-cysteine4-nitrophenylester |
| DTXSID90930943 |
| dihydroergotoxinemesylate |
| A50215 |
| crffpdbjlgagql-uhfffaoysa-n |
| SY116236 |
| EN300-1934910 |
| CS-0157571 |
| PD196933 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 13.28
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.28) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||